Laure Joachim1, Dioclecio Campos, Pierre R Smeesters. 1. Department of Pediatrics, Queen Fabiola Unversity Children's Hospital, Institute for Molecular Biology and Medicine, Free University of Brussels, Brussels, Belgium.
Abstract
OBJECTIVE: Our objective was to develop an easy, safe, pragmatic, clinical scoring system that would allow decreases in unnecessary treatment with antimicrobial agents in low-resource settings. METHODS: Children with pharyngitis were enrolled prospectively from 2 public hospitals and 1 medical unit in Brasilia, Brazil, over 17 months. Attending clinicians completed a questionnaire and a previously published scoring system for pharyngitis before performing throat swabs and group A streptococcus (GAS) rapid antigen-detection tests. Data from this study were added to those collected in 2004, to assess the performance of each item of the scoring system. The performance of the new clinical decision rule was determined with a receiver operating characteristic curve. The final outcome of the model was assessed on the basis of sensitivity, specificity, and positive likelihood ratio for non-GAS infections with the clinical approach, compared with throat culture or rapid antigen-detection test results. RESULTS: A total of 576 children were included, among whom 400 had non-GAS pharyngitis. The use of our new clinical decision rule would allow for 35% to 55% antibiotic reduction, with 88% specificity. CONCLUSIONS: This clinical decision rule could reduce unnecessary antibiotic treatment significantly in low-resource settings.
OBJECTIVE: Our objective was to develop an easy, safe, pragmatic, clinical scoring system that would allow decreases in unnecessary treatment with antimicrobial agents in low-resource settings. METHODS:Children with pharyngitis were enrolled prospectively from 2 public hospitals and 1 medical unit in Brasilia, Brazil, over 17 months. Attending clinicians completed a questionnaire and a previously published scoring system for pharyngitis before performing throat swabs and group A streptococcus (GAS) rapid antigen-detection tests. Data from this study were added to those collected in 2004, to assess the performance of each item of the scoring system. The performance of the new clinical decision rule was determined with a receiver operating characteristic curve. The final outcome of the model was assessed on the basis of sensitivity, specificity, and positive likelihood ratio for non-GAS infections with the clinical approach, compared with throat culture or rapid antigen-detection test results. RESULTS: A total of 576 children were included, among whom 400 had non-GASpharyngitis. The use of our new clinical decision rule would allow for 35% to 55% antibiotic reduction, with 88% specificity. CONCLUSIONS: This clinical decision rule could reduce unnecessary antibiotic treatment significantly in low-resource settings.
Authors: Milagritos D Tapia; Samba O Sow; Boubou Tamboura; Mahamadou M Keita; Abdoulaye Berthe; Mariam Samake; James P Nataro; Uma O Onwuchekwa; Thomas A Penfound; William Blackwelder; James B Dale; Karen L Kotloff Journal: Pediatr Infect Dis J Date: 2015-05 Impact factor: 2.129
Authors: Eileen M Dunne; Julia L Marshall; Ciara A Baker; Jayne Manning; Gena Gonis; Margaret H Danchin; Pierre R Smeesters; Catherine Satzke; Andrew C Steer Journal: BMC Infect Dis Date: 2013-07-11 Impact factor: 3.090
Authors: Aurelino Rocha Barbosa Júnior; Cláudia Di Lorenzo Oliveira; Maria Jussara Fernandes Fontes; Laura Maria de Lima Bezário Facury Lasmar; Paulo Augusto Moreira Camargos Journal: Rev Paul Pediatr Date: 2014-12
Authors: Timothy S Uphoff; Blake W Buchan; Nathan A Ledeboer; Paul A Granato; Judy A Daly; Tara N Marti Journal: J Clin Microbiol Date: 2016-06-29 Impact factor: 5.948
Authors: Mustafa Kolukirik; Mesut Yılmaz; Orhan Ince; Canan Ketre; Ayşe Istanbullu Tosun; Bahar K Ince Journal: Ann Clin Microbiol Antimicrob Date: 2016-08-08 Impact factor: 3.944